Heart Attack :: Fish oil good for heart attack patients
Fish oil supplements are considered good for heart attack patients, and could prevent a repeat attack of survivors of cardiac arrest, MI.
Fish oil supplements are considered good for heart attack patients, and could prevent a repeat attack of survivors of cardiac arrest, MI.
The following is a Statement from the American College of Cardiology, American Diabetes Association and American Heart Association Related to NEJM article, ‘Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes’:
Cardiovascular disease (heart disease, stroke and vascular disease) affects nearly one in five Australians and about 65% of those take medicines for their condition.
Sleep apnea is associated with a greatly increased incidence of pregnancy-induced diabetes and high blood pressure, according to a study presented at the American Thoracic Society 2007 International Conference, on Wednesday, May 22.
UAB (University of Alabama at Birmingham) has opened one of the few clinics in the nation dedicated to providing services to adult patients with Down Syndrome.
Two recent Mayo Clinic studies have found that magnetic resonance elastography (MRE), a new imaging technique invented at Mayo Clinic, is an accurate tool for non-invasive diagnosis of liver diseases.
NewYork-Presbyterian Hospital/Weill Cornell Medical Center urologists are presenting exciting new research at the 2007 American Urological Association (AUA) Conference in Anaheim, May 19?May 24. Among the most significant presentations are the following:
Metabolic syndrome is characterized by a number of conditions, including elevated blood pressure, excess body fat around the waist and insulin resistance.
A new UCLA imaging study reveals how inhaling 100 percent oxygen can harm the brain. The findings fly in the face of national guidelines for resuscitation and urge a new approach adding carbon dioxide to the gas mix to preserve brain function in patients.
Researchers at the University of Minnesota and the University of Illinois at Urbana-Champaign have developed a new therapeutic that neutralizes Toxic Shock Syndrome (TSS) more effectively than other treatments.